跳至主要内容
临床试验/NCT01554748
NCT01554748Unknown不适用

Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint

Regional Hospital Holstebro1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2008年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
400
试验地点
1
主要终点
Implant survival

研究概览

简要总结

The study evaluates implant survival in total joint arthroplasty of the Trapeziometacarpal (TMC) joint by monitoring the survival of different implant types using radiostereometry (RSA) evaluation of the implants.

详细描述

The study evaluates implant survival and clinical outcome in total joint arthroplasty of the TMC joint. Different implant designs are included in the study both cemented and uncemented implants. Also the influence of patient factors and surgical technique on implant survival is investigated. The primary outcome is implant migration and loosening. Evaluation is done by monitoring migration and loosening of different implant types using RSA evaluation of the implants. Secondary outcomes are patient reported function evaluated with the Disability of the arm, shoulder and hand score (DASH) and visual analog pain score (VAS). Tertiary outcome is range of movement (ROM) plus grip strength.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with Eaton type 2+3 TMC osteoarthritis

排除标准

  • •Patients with Eaton type 4 TMC osteoarthritis

研究组 & 干预措施

Patient cohort

Other

TMC total joint arthroplasty

干预措施: Total joint arthroplasty (Procedure)

结局指标

主要结局

Implant survival

时间窗: 10 year survival

Revision with removal of implant

次要结局

未报告次要终点

研究者

发起方
Regional Hospital Holstebro
申办方类型
Other
责任方
Principal Investigator
主要研究者

Torben B. Hansen

Professor, MD, PhD

Regional Hospital Holstebro

研究点 (1)

Loading locations...

相似试验

Improvement of Implant Survival in Total Joint... | 临床试验